FASTinov is an innovation-based company that develops next generation Antimicrobial resistance technologies. The company launched the world’s fastest susceptibility test, which delivers a result in less than 2 hours for bloodstream infections. These are life-threatening conditions often associated with sepsis, a condition that kills more than 10 million people annually. The emergence of bacterial species resistant to antimicrobials further increases the urgency of providing rapid diagnostics.
FASTinov’s mission is to bring the fastest technologies to help in the fight against life-threatening infections.
FASTinov SA was established in 2013 by clinicians from the University of Porto, Faculty of Medicine and is headquartered in Porto, Portugal.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Rua Alfredo Allen 455, Porto,portugal
- in****@****nov.com
- Industry
- Medical Device
- Website
- fastinov.com
- Keywords
- in-vitro diagnostics, Flow Cytometry, Antimicrobial Susceptibility Testing, Microbiology, AMR, Sepsis, Antimicrobial resistance, Next-generation AST.
- HQ
- Porto
Fastinov Sa Questions
Fastinov Sa's website is fastinov.com
Fastinov Sa's LinkedIn profile is https://pt.linkedin.com/company/fastinov
Fastinov Sa has
12 employees.
View email and phone details for 12
employees at Fastinov Sa.
Fastinov Sa's industry is
Medical Device
Fastinov Sa's top competitors are
Gradientech,
Breederode Hogeschool,
Nvfg,
Bioref - Collaborative Laboratory (Colab),
Quilaban,
Bsim Therapeutics,
Ifast Diagnostics,
Eit Health,
Biopremier - Production And Development,
Corium Biotech.
Fastinov Sa's support email address is info@fastinov.com
Fastinov Sa's categories are Medical Device
Fastinov Sa's founding year is 2013
